On Monday shares of CTI BioPharma Corp. (NASDAQ:CTIC) closed at $1.93. Company’s sales growth for last 5 years was 259.60%. Stock analysts at Roth Capital set a $4.50 target price on shares of CTI BioPharma Corp. (NASDAQ:CTIC) stock in a report issued on Monday. The firm currently has a a “buy” rating on the stock. Roth Capital’s target price would indicate a potential upside of 131.36% from the stock’s previous close.
On Monday shares of The Medicines Company (NASDAQ:MDCO) closed at $29.30. Company’s sales growth for last 5 years was 12.40% and EPS growth for next 5 years is recorded as 10.00%. On 10 April, The Medicines Company (NASDAQ:MDCO) announced preliminary revenue for the first quarter of 2015. The company expects net revenue in the range of $125 million to $130 million for Q1, a 29 to 26 percent decrease from the $177.2 million in 2014.
Biogen Inc. (NASDAQ:BIIB) in last trading activity decreased -0.54% to close at $423.36. Company weekly performance is 2.40% while its quarterly performance stands at 23.67%. Biogen Inc. (NASDAQ:BIIB) is -11.83% away from its 52 week high. Biogen Inc. (NASDAQ:BIIB) announced it will report first quarter 2015 financial results on Friday, April 24, 2015, before the financial markets open.
On last trading day ArQule Inc. (NASDAQ:ARQL) advanced 2.78% to close at $2.22. Its volatility for the week is 4.56% while volatility for the month is 7.41%. ARQL’s sales growth for past 5 years was -14.80% and its EPS growth for past 5 years was 14.70%. ArQule Inc. (NASDAQ:ARQL) monthly performance is -3.48%. ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the 14th Annual Needham Healthcare Conference on Tuesday, April 14, 2015 at 3:00 p.m.
Ford Motor Company (NYSE:F) has 0.10% insider ownership while its institutional ownership stands at 59.20%. In last trading activity company’s stock closed at $15.87. On 10 April, Ford Motor Company (NYSE:F) said it had taken control of its Russian venture with Russian car company Sollers and would provide it with additional financial support.